Literature DB >> 3121918

A model for follicular selection and ovulation: lessons from superovulation.

D T Baird1.   

Abstract

A model for selection of the preovulatory follicle during the normal ovarian cycle is proposed. During menstruation the concentration of FSH rises to a level high enough to "activate" a single small antral follicle (2-4 mm dia.) so that it can produce large amounts of oestradiol. As the follicle develops, the concentration of FSH is suppressed below this threshold level by the secretion of oestradiol and inhibin. The dominant follicle becomes increasingly sensitive to FSH so that it continues to develop in an environment which inhibits development of other follicles. Multiple ovulation can be achieved by extending the period during which the level of FSH remains above this threshold level (e.g. during treatment with clomiphene or gonadotrophins). Although multiple ovulation occurs when the gate is widened in this way, the follicles are never completely synchronous as they continue to grow at approximately the same rate. Current evidence suggests that ovulation occurs at random between the two ovaries in successive cycles and that the corpus luteum exerts an inhibitory effect on folliculogenesis by suppressing the secretion of FSH and LH. These observations are compatible with the hypothesis that while small antral follicles are recruited continuously, at all stages of reproductive life, selection of the dominant follicle requires the unique gonadotrophic environment which is only present in the early follicular phase. The follicle of the month is, therefore, selected by chance because it is at the right place at the right time.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121918     DOI: 10.1016/0022-4731(87)90289-5

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  12 in total

1.  Endometrial development in association with ovarian follicular waves during the menstrual cycle.

Authors:  A R Baerwald; R A Pierson
Journal:  Ultrasound Obstet Gynecol       Date:  2004-09       Impact factor: 7.299

Review 2.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

3.  Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.

Authors:  Iro Karagiorga; George A Partsinevelos; Despina Mavrogianni; Elli Anagnostou; Ioannis Zervomanolakis; Konstantinos Kallianidis; Petros Drakakis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2014-12-27       Impact factor: 3.412

4.  The Relationship Between Progesterone, Sleep, and LH and FSH Secretory Dynamics in Early Postmenarchal Girls.

Authors:  Bob Z Sun; Tairmae Kangarloo; Judith M Adams; Patrick Sluss; Donald W Chandler; David T Zava; John A McGrath; David M Umbach; Natalie D Shaw
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

5.  Superovulation with a high gonadotropin dose for in vitro fertilization: is it effective?

Authors:  H Lashen; W Ledger; A López Bernal; B Evans; D Barlow
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

Review 6.  Contemporary pharmacological manipulation in assisted reproduction.

Authors:  Judith A F Huirne; Cornelis B Lambalk; Andre C D van Loenen; Roel Schats; Peter G A Hompes; Bart C J M Fauser; Nick S Macklon
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Current trends in the treatment of polycystic ovary syndrome with desire for children.

Authors:  Margalida E Sastre; Maria O Prat; Miguel Angel Checa; Ramon C Carreras
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

8.  Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome.

Authors:  Mika Kanaya; Tsuyoshi Baba; Yoshimitsu Kitajima; Keiko Ikeda; Ayumi Shimizu; Miyuki Morishita; Hiroyuki Honnma; Toshiaki Endo; Tsuyoshi Saito
Journal:  Int J Womens Health       Date:  2012-08-24

9.  Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols.

Authors:  Neena Malhotra; Akhilesh Srivastava; Harpal Rana; Anupama Bahadur; Jayasree Sengupta; Debabrata Ghosh
Journal:  J Hum Reprod Sci       Date:  2013-07

10.  Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment.

Authors:  Peter J Illingworth; Robert Lahoud; Frank Quinn; Kendal Chidwick; Claire Wilkinson; Gavin Sacks
Journal:  Patient Prefer Adherence       Date:  2014-06-05       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.